Rense.com



Think Twice About Hormone
Replacement Therapy

By Paul Majendie
10-9-2

=FRANKFURT, Germany (Reuters) - Think twice about Hormone Replacement Therapy (HRT) drugs, say the authors of an upcoming book on the treatment taken by millions of women to relieve symptoms of the menopause.
 
"Far more research needs to be done about these drugs," said British investigative journalist Jackie Williams, co-author of "The Estrogen Myth Exposed," which is set to stir interest among publishers at this year's Frankfurt book fair.
 
Women who use HRT to relieve hot flashes and mood swings or to prevent osteoporosis were caught off guard in July after a U.S. trial showed HRT raises the risk of stroke, breast cancer and blood clots. Shares in HRT manufacturers like the U.S-based Wyeth and Germany's Schering tumbled.
 
Then last month a British study backed the U.S. findings, concluding that women who took the treatment for five years had a higher risk of breast cancer, stroke and blood clots in the lung but were overall less likely to suffer from bowel cancer or hip fractures.
 
In an interview with Reuters, Williams said she and co-author Helen Woollin had been working for women's voluntary health organizations for some years and realized there was a huge gap in knowledge about HRT drugs.
 
"We have been looking into 40 years of research into women's menopausal problems and we have a stark message for them: 'Be careful taking any synthetic hormones as you may be causing the very diseases you are trying to prevent,"' she said.
 
She called on the medical profession to be much more aware of any possible side effects.
 
"We have been contacted by many hundreds of women who have incurred health problems due to these drugs. Their doctors have not been able to help them," she said.
 
"I think doctors should be far more informed about the nutritional aspects of health," she added. "These latest trials and studies have confirmed what has been evident to a lot of people for a long time."
 
In the U.S. study of 16,600 women, HRT was shown to lower the risk of osteoporosis, or brittle bone disease, and colon cancer. But it raised the number of strokes by 41 percent, heart attack by 29 percent and breast cancer by 26 percent.
 
The book's British publishers say they are firmly convinced its timing is topical.
 
"We have received very strong international interest," said Fiona Langdon, International Sales Director of Virgin Books.
 
Williams said that women around the world should be much more questioning about how they treat their bodies.
 
"Up till now, medical opinion currently assumed that estrogen production ceased at menopause and that all women need this treatment to remain healthy. This is often far from the truth," she said.
 
"By prescribing more and more estrogen and other synthetic hormones, doctors may increase the risk of disease."
 
Calling for more money to be spent on research into the side effects of HRT, she concluded: "I think drugs should not be the first resort for women's symptoms of menopause."
 
 
Copyright © 2002 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.





MainPage
http://www.rense.com


This Site Served by TheHostPros